Related references
Note: Only part of the references are listed.Extended results of the Alzheimer's disease anti-inflammatory prevention trial
John C. Breitner et al.
ALZHEIMERS & DEMENTIA (2011)
Colocalisation of plasma derived apo B lipoproteins with cerebral proteoglycans in a transgenic-amyloid model of Alzheimer's disease
Virginie Lam et al.
NEUROSCIENCE LETTERS (2011)
Beneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase III
C. C. McGown et al.
BRITISH JOURNAL OF ANAESTHESIA (2010)
Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-β
Ryusuke Takechi et al.
BRITISH JOURNAL OF NUTRITION (2010)
Anti-inflammatory treatment in AD mice protects against neuronal pathology
Ji-Kyung Choi et al.
EXPERIMENTAL NEUROLOGY (2010)
Age-Varying Association Between Statin Use and Incident Alzheimer's Disease
Ge Li et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)
Inflammation, Cytokines, Immune Response, Apolipoprotein E, Cholesterol, and Oxidative Stress in Alzheimer Disease: Therapeutic Implications
Giuseppina Candore et al.
REJUVENATION RESEARCH (2010)
Vascular pathology in Alzheimer's disease
Taihei Miyakawa
PSYCHOGERIATRICS (2010)
Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk
Elizabeth E. Devore et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
Blood-brain barrier alterations in ageing and dementia
Bogdan O. Popescu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Dietary saturated and unsaturated fats as determinants of blood pressure and vascular function
Wendy L. Hall
NUTRITION RESEARCH REVIEWS (2009)
Benefits from Dietary Polyphenols for Brain Aging and Alzheimer's Disease
L. Rossi et al.
NEUROCHEMICAL RESEARCH (2008)
Protective effects of NSAIDs on the development of Alzheimer disease
Steven C. Vlad et al.
NEUROLOGY (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy
Hwa Kyoung Shin et al.
BRAIN (2007)
Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions
Yoshihisa Shitara et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function
Stephen J. Nicholls et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus
Qun Wang et al.
BRAIN RESEARCH (2006)
Fat intake at midlife and risk of dementia and Alzheimer's disease: A population-based study
M. H. Laitinen et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats
AD Mooradian et al.
DIABETES (2005)
Ibuprofen suppresses interleukin-1β induction of pro-amyloidogenic α1-antichymotrypsin to ameliorate β-amyloid (Aβ) pathology in Alzheimer's models
T Morihara et al.
NEUROPSYCHOPHARMACOLOGY (2005)
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia -: The Three-City Study
C Dufouil et al.
NEUROLOGY (2005)
Effects of atorvastatin on blood-brain barrier permeability during L-NAME hypertension followed by angiotensin-II in rats
R Kalayci et al.
BRAIN RESEARCH (2005)
Synaptic localization of a functional NADPH oxidase in the mouse hippocampus
MV Tejada-Simon et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2005)
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
M Schachter
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)
Lipids, diet and Alzheimer disease: an extended summary
GJ Petot et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Mechanisms of action of dietary fatty acids in regulating the activation of vascular endothelial cells during atherogenesis
RA Christon
NUTRITION REVIEWS (2003)
Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss
JJ Kril et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Midlife vascular risk factors and Alzheimer's disease in later life:: longitudinal, population based study
M Kivipelto et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
B Wolozin et al.
ARCHIVES OF NEUROLOGY (2000)
Share Paper
